LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Hims & Hers brings former Amazon executive into C-suite

Robert Frost by Robert Frost
May 5, 2025
in Industries
Hims & Hers brings former Amazon executive into C-suite
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally.

Courtesy: Hims & Hers

Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped establish many of its health-care offerings, will join the telehealth company as its chief operations officer.

Kabbani spent nearly 20 years at Amazon, where he oversaw the launch of Amazon Pharmacy, the company’s acquisition of PillPack and its global Covid-19 Vaccination Task Force. He also helped stand up Amazon Kindle, Amazon Logistics, Amazon Music and Prime Video services.

Hims & Hers offers a range of direct-to-consumer treatments for conditions such as erectile dysfunction and hair loss. The company, which saw revenue increase 69% last year, said Kabbani will help the company continue to grow and scale.

“Nader’s experience scaling operations at the highest level makes him uniquely qualified to help us build the future of healthcare,” Hims and Hers CEO Andrew Dudum said in a statement.

In addition to his experience at Amazon, Kabbani also held executive leadership roles at the supply chain logistics company Flexport and the warehouse automation company Symbotic.

Stock Chart IconStock chart icon

Hims & Hers shares over six months.

Hims & Hers shares had a volatile start to the year, notching several double-digit moves over the past few months. Investors have been paying close attention to the company’s weight loss offering, which was thrown into question after the U.S. Food and Drug Administration announced changes to the medication supply environment earlier this year.

Shares of the company closed up 23% on April 29, for instance, after Novo Nordisk said it would offer its weight loss drug Wegovy through telehealth providers like Hims & Hers.

The stock was down more than 1% on Monday but was up more than 70% year to date.

Hims & Hers is slated to report earnings after market close.

Don’t miss these insights from CNBC PRO

Hims & Hers shares rise as company adds Eli Lilly's Zepbound



Source link

You might also like

Volvo reveals EX60 SUV, its fastest charging EV yet – and an offroad surprise

Is the Hyundai IONIQ 5 the best bang for your buck for an EV?

Tesla quietly cuts 1,700 jobs at Gigafactory Berlin despite denying it

Share30Tweet19
Previous Post

Charts show this China tech ETF could be a better bet than U.S. tech, says Katie Stockton

Next Post

What happens to the ‘Buffett premium’ in Berkshire’s stock? Analysts expect short-term pressure

Robert Frost

Robert Frost

Jutawantoto Jutawantoto Jutawantoto Jutawantoto Berita Terbaru Hari

Recommended For You

Volvo reveals EX60 SUV, its fastest charging EV yet – and an offroad surprise
Industries

Volvo reveals EX60 SUV, its fastest charging EV yet – and an offroad surprise

January 21, 2026
Is the Hyundai IONIQ 5 the best bang for your buck for an EV?
Industries

Is the Hyundai IONIQ 5 the best bang for your buck for an EV?

January 21, 2026
Tesla quietly cuts 1,700 jobs at Gigafactory Berlin despite denying it
Industries

Tesla quietly cuts 1,700 jobs at Gigafactory Berlin despite denying it

January 21, 2026
Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
Industries

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

January 21, 2026
Next Post
What happens to the ‘Buffett premium’ in Berkshire’s stock? Analysts expect short-term pressure

What happens to the ‘Buffett premium’ in Berkshire’s stock? Analysts expect short-term pressure

Related News

Arteta is ready to unleash a new Arsenal strikeforce

Arteta is ready to unleash a new Arsenal strikeforce

December 12, 2025
Tesla starts Supervised Full Self-Driving v12.5 wide release

Tesla starts Supervised Full Self-Driving v12.5 wide release

July 29, 2024
Crosstree and Bloom pay £20m for pair of London industrial estates | Property Week

Crosstree and Bloom pay £20m for pair of London industrial estates | Property Week

July 15, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • jutawantoto
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?